Ignite Creation Date:
2024-05-06 @ 4:22 PM
Last Modification Date:
2024-10-26 @ 2:09 PM
Study NCT ID:
NCT04965493
Status:
RECRUITING
Last Update Posted:
2024-07-03
First Post:
2021-07-15
Brief Title:
A Trial of Pirtobrutinib LOXO-305 Plus Venetoclax and Rituximab PVR Versus Venetoclax and Rituximab VR in Previously Treated Chronic Lymphocytic LeukemiaSmall Lymphocytic Lymphoma CLLSLL
Sponsor:
Loxo Oncology Inc
Organization:
Eli Lilly and Company